WallStreetZenWallStreetZen

NASDAQ: OMIC
Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for OMIC

Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc.
Min Forecast
$1.00+180.11%
Avg Forecast
$1.00+180.11%
Max Forecast
$1.00+180.11%

Should I buy or sell OMIC stock?

Based on 1 analyst offering ratings for Singular Genomics Systems Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OMIC stock forecasts and price targets.

OMIC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Goldman Sachs
Bottom 4%
4
HoldMaintains$1.00+180.11%2023-08-10

1 of 1

Forecast return on equity

Is OMIC forecast to generate an efficient return?
Company
-41.52%
Industry
16.71%
Market
48.56%
OMIC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OMIC forecast to generate an efficient return on assets?
Company
-31.93%
Industry
10.27%
OMIC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OMIC revenue growth forecast

How is OMIC forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
535.26%
Industry
4.59%
Market
12.79%
OMIC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OMIC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OMIC vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
OMIC$0.36$1.00+180.11%Hold
RVP$1.21N/AN/A
MBOT$1.36$8.00+488.24%Buy
NEPH$1.46N/AN/A
POCI$6.15N/AN/A
View Top Medical Stocks

Singular Genomics Systems Stock Forecast FAQ

Is Singular Genomics Systems Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: OMIC) stock is to Hold OMIC stock.

Out of 1 analyst, 0 (0%) are recommending OMIC as a Strong Buy, 0 (0%) are recommending OMIC as a Buy, 1 (100%) are recommending OMIC as a Hold, 0 (0%) are recommending OMIC as a Sell, and 0 (0%) are recommending OMIC as a Strong Sell.

If you're new to stock investing, here's how to buy Singular Genomics Systems stock.

What is OMIC's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: OMIC) forecast ROE is -41.52%, which is considered weak.

What is OMIC's Price Target?

According to 1 Wall Street analyst that have issued a 1 year OMIC price target, the average OMIC price target is $1.00, with the highest OMIC stock price forecast at $1.00 and the lowest OMIC stock price forecast at $1.00.

The Wall Street analyst predicted that Singular Genomics Systems's share price could reach $1.00 by Aug 10, 2024. The average Singular Genomics Systems stock price prediction forecasts a potential upside of 180.11% from the current OMIC share price of $0.36.

What is OMIC's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: OMIC) forecast ROA is -31.93%, which is lower than the forecast US Medical Instruments & Supplies industry average of 10.27%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.